Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Saltiel

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
La Revue Du Praticien|May 21, 1974
[Air pollution in the home]J Chrétien, H Amadei, N Donat, et al.
Therapie|November 1, 1976
[Comparison of 2 methods of determination of serum INH. (study in 50 patients)]D Thenault, J C Saltiel, G Houin, et al.
Annales De Dermatologie Et De Venereologie|May 12, 2005
[Lingual tuberculosis associated with disseminated tuberculosis]N Girszyn, A Belmekki, M Duterque, et al.
La Nouvelle Presse Medicale|October 1, 1977
[Modification during treatment of the rate of acetylation of isoniazide clinically or biologically detectable hepatic damage (author's transl)]E Albengres, G Houin, J L Breau, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Severe mucositis after chemotherapy with vinorelbine, 5-fluorouracil, leucovorin and cisplatinI Monnet, P Chariot, N Azli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1992
Extensive small-cell lung cancer. A randomized comparison of two chemotherapy programs with early crossover in instances of failure. Association pour le Traitement des Tumeurs Intra-Thoraciques (ATTIT)I Monnet, P Chariot, E Quoix, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Cisplatin and continuous infusion vindesine and 5-fluorouracil in non-small cell lung cancer (NSCLC) (ATTIT 002). ATTIT (Association pour le Traitment des Tumeurs Intra-Thoraciques)M Riggi, E Cvitkovic, H de Cremoux, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Influence of pretreatment clinical characteristics on the response rate to mitomycin/vindesine/cisplatin (MVP) in unresectable non-small cell lung cancer. ATTIT (Association pour le Traitement des Tumeurs Intra-Thoraciques)M Riggi, P Ruffie, S Voisin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Phase I/II study of escalating doses of vinorelbine in combination with oxaliplatin in patients with advanced non-small-cell lung cancerI Monnet, P Soulié, H de Cremoux, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Phase II study of oxaliplatin in poor-prognosis non-small cell lung cancer (NSCLC). ATTIT. Association pour le Traitement des Tumeurs Intra ThoraciquesI Monnet, S Brienza, F Hugret, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
La Revue Du Praticien|May 21, 1974
[Air pollution in the home]J Chrétien, H Amadei, N Donat, et al.
Therapie|November 1, 1976
[Comparison of 2 methods of determination of serum INH. (study in 50 patients)]D Thenault, J C Saltiel, G Houin, et al.
Annales De Dermatologie Et De Venereologie|May 12, 2005
[Lingual tuberculosis associated with disseminated tuberculosis]N Girszyn, A Belmekki, M Duterque, et al.
La Nouvelle Presse Medicale|October 1, 1977
[Modification during treatment of the rate of acetylation of isoniazide clinically or biologically detectable hepatic damage (author's transl)]E Albengres, G Houin, J L Breau, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Severe mucositis after chemotherapy with vinorelbine, 5-fluorouracil, leucovorin and cisplatinI Monnet, P Chariot, N Azli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1992
Extensive small-cell lung cancer. A randomized comparison of two chemotherapy programs with early crossover in instances of failure. Association pour le Traitement des Tumeurs Intra-Thoraciques (ATTIT)I Monnet, P Chariot, E Quoix, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Cisplatin and continuous infusion vindesine and 5-fluorouracil in non-small cell lung cancer (NSCLC) (ATTIT 002). ATTIT (Association pour le Traitment des Tumeurs Intra-Thoraciques)M Riggi, E Cvitkovic, H de Cremoux, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Influence of pretreatment clinical characteristics on the response rate to mitomycin/vindesine/cisplatin (MVP) in unresectable non-small cell lung cancer. ATTIT (Association pour le Traitement des Tumeurs Intra-Thoraciques)M Riggi, P Ruffie, S Voisin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Phase I/II study of escalating doses of vinorelbine in combination with oxaliplatin in patients with advanced non-small-cell lung cancerI Monnet, P Soulié, H de Cremoux, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Phase II study of oxaliplatin in poor-prognosis non-small cell lung cancer (NSCLC). ATTIT. Association pour le Traitement des Tumeurs Intra ThoraciquesI Monnet, S Brienza, F Hugret, et al.
Pageof 3